Charles Schwab Investment Management Inc Fulgent Genetics, Inc. Transaction History
Charles Schwab Investment Management Inc
- $521 Billion
- Q1 2025
A detailed history of Charles Schwab Investment Management Inc transactions in Fulgent Genetics, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 243,979 shares of FLGT stock, worth $5.04 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
243,979
Previous 210,211
16.06%
Holding current value
$5.04 Million
Previous $3.88 Million
6.21%
% of portfolio
0.0%
Previous 0.0%
Shares
20 transactions
Others Institutions Holding FLGT
# of Institutions
197Shares Held
18.2MCall Options Held
379KPut Options Held
52.9K-
Black Rock Inc. New York, NY3.92MShares$81 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.97MShares$40.7 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.17MShares$24.1 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX1.03MShares$21.3 Million0.0% of portfolio
-
Acadian Asset Management LLC Boston, MA806KShares$16.7 Million0.04% of portfolio
About Fulgent Genetics, Inc.
- Ticker FLGT
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 30,265,800
- Market Cap $626M
- Description
- Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...